TY - JOUR
T1 - Necroptosis
T2 - Mechanisms and Relevance to Disease
AU - Galluzzi, Lorenzo
AU - Kepp, Oliver
AU - Chan, Francis Ka Ming
AU - Kroemer, Guido
N1 - Publisher Copyright:
© 2017 by Annual Reviews. All rights reserved.
PY - 2017/1/24
Y1 - 2017/1/24
N2 - Necroptosis is a form of regulated cell death that critically depends on receptor-interacting serine-threonine kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL) and generally manifests with morphological features of necrosis. The molecular mechanisms that underlie distinct instances of necroptosis have just begun to emerge. Nonetheless, it has already been shown that necroptosis contributes to cellular demise in various pathophysiological conditions, including viral infection, acute kidney injury, and cardiac ischemia-reperfusion. Moreover, human tumors appear to obtain an advantage from the downregulation of key components of the molecular machinery for necroptosis. Although such an advantage may stem from an increased resistance to adverse microenvironmental conditions, accumulating evidence indicates that necroptosis-deficient cancer cells are poorly immunogenic and hence escape natural and therapy-elicited immunosurveillance. Here, we discuss the molecular mechanisms and relevance to disease of necroptosis.
AB - Necroptosis is a form of regulated cell death that critically depends on receptor-interacting serine-threonine kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL) and generally manifests with morphological features of necrosis. The molecular mechanisms that underlie distinct instances of necroptosis have just begun to emerge. Nonetheless, it has already been shown that necroptosis contributes to cellular demise in various pathophysiological conditions, including viral infection, acute kidney injury, and cardiac ischemia-reperfusion. Moreover, human tumors appear to obtain an advantage from the downregulation of key components of the molecular machinery for necroptosis. Although such an advantage may stem from an increased resistance to adverse microenvironmental conditions, accumulating evidence indicates that necroptosis-deficient cancer cells are poorly immunogenic and hence escape natural and therapy-elicited immunosurveillance. Here, we discuss the molecular mechanisms and relevance to disease of necroptosis.
KW - Caspases
KW - Damage-associated molecular patterns
KW - Immunogenic cell death
KW - Inflammation
KW - Mitochondrial permeability transition
KW - Necrostatin-1
UR - http://www.scopus.com/inward/record.url?scp=85011258194&partnerID=8YFLogxK
U2 - 10.1146/annurev-pathol-052016-100247
DO - 10.1146/annurev-pathol-052016-100247
M3 - Review article
C2 - 27959630
AN - SCOPUS:85011258194
SN - 1553-4006
VL - 12
SP - 103
EP - 130
JO - Annual Review of Pathology: Mechanisms of Disease
JF - Annual Review of Pathology: Mechanisms of Disease
ER -